CCL14 and acute kidney injury: CCL14 biomarker results > 13 ng/mL increase the level of concern to modify the AKI treatment plan and are informative for certain aspects of AKI management and care processes, including discussion on RRT initiation, strict urine output monitoring and diuretic management.